Intersection of diverse neuronal genomes and neuropsychiatric disease: The Brain Somatic Mosaicism Network

Science

Volumn 356, Issue 6336, 2017, Pages

  McConnell, Michael J ^a   Moran, John V ^b   Abyzov, Alexej ^c   Akbarian, Schahram ^d   Bae, Taejeong ^c   Cortes Ciriano, Isidro ^e   Erwin, Jennifer A ^f   Fasching, Liana ^g   Flasch, Diane A ^b   Freed, Donald ^h,i   Ganz, Javier ^e,j,t   Jaffe, Andrew E ^k   Kwan, Kenneth Y ^b   Kwon, Minseok ^e   Lodato, Michael A ^e,j,t   Mills, Ryan E ^b   Paquola, Apua C M ^f   Rodin, Rachel E ^e,j,t   Rosenbluh, Chaggai ^l   Sestan, Nenad ^m   Sherman, Maxwell A ^e   Shin, Joo Heon ^k   Song, Saera ^n,o   Straub, Richard E ^k   Thorpe, Jeremy ^h,i   Weinberger, Daniel R ^i,k,p   Urban, Alexander E ^q   Zhou, Bo ^q   Gage, Fred H ^f   Lehner, Thomas ^r   Senthil, Geetha ^r   Walsh, Christopher A ^e,j,t   Chess, Andrew ^l   Courchesne, Eric ^s   Gleeson, Joseph G ^n,o   Kidd, Jeffrey M ^b   Park, Peter J ^e   Pevsner, Jonathan ^h,i   Vaccarino, Flora M ^g,m   more..

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MAYO CLINIC   (United States)

^d HESS CORPORATION   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h KENNEDY KRIEGER INSTITUTE   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j BOSTON CHILDREN S HOSPITAL   (United States)

^k LIEBER INSTITUTE FOR BRAIN DEVELOPMENT   (United States)

^l MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^m YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ ROCKEFELLER UNIVERSITY   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p Departments of Psychiatry and Behavioral Sciences and Neuroscience   (United States)

^q STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^s UNIVERSITY OF CALIFORNIA   (United States)

^t BROAD INSTITUTE OF MIT AND HARVARD   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; CELLS AND CELL COMPONENTS; DISEASE INCIDENCE; DNA; GENOME; METABOLISM; MUTATION; NERVOUS SYSTEM DISORDER; PROTEIN; PROTEOMICS;

ARTICLE; AUTISM; BIPOLAR DISORDER; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED CLINICAL TRIAL (TOPIC); GENETIC SUSCEPTIBILITY; GENOME; HUMAN; LIFESPAN; MENTAL DISEASE; MOSAICISM; NERVE CELL; NERVE CELL DIFFERENTIATION; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SOMATIC MUTATION; WHOLE GENOME SEQUENCING; ABNORMALITIES; BRAIN; CELL DIVISION; DNA DAMAGE; DNA MUTATIONAL ANALYSIS; DNA REPAIR; DNA REPLICATION; GENETICS; GERM CELL; GROWTH, DEVELOPMENT AND AGING; HUMAN GENOME; METABOLISM; NERVE CELL NETWORK; NEURAL STEM CELL; NEUROLOGIC DISEASE; PHYSIOLOGY; PROCEDURES;

BRAIN; CELL DIVISION; DNA DAMAGE; DNA MUTATIONAL ANALYSIS; DNA REPAIR; DNA REPLICATION; GENOME, HUMAN; GERM CELLS; HUMANS; MENTAL DISORDERS; MOSAICISM; NERVE NET; NERVOUS SYSTEM DISEASES; NEURAL STEM CELLS; NEURONS;

EID: 85018280420     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aal1641     Document Type: Article

References (139)

1. M. Lynch, Rate, molecular spectrum, and consequences of human mutation. Proc. Natl. Acad. Sci. U.S.A. 107, 961-968 (2010). doi: 10.1073/pnas.0912629107; pmid: 20080596
2. D. Freed, E. L. Stevens, J. Pevsner, Somatic mosaicism in the human genome. Genes (Basel) 5, 1064-1094 (2014). doi: 10.3390/genes5041064; pmid: 25513881
3. S. A. Frank, Evolution in health and medicine Sackler colloquium: Somatic evolutionary genomics: Mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 107 (suppl. 1), 1725-1730 (2010). doi: 10.1073/pnas.0909343106; pmid: 19805033
4. J. R. Lupski, Genome mosaicism-One human, multiple genomes. Science 341, 358-359 (2013). doi: 10.1126/science.1239503; pmid: 23888031
5. M. A. Lodato et al., Somatic mutation in single human neurons tracks developmental and transcriptional history. Science 350, 94-98 (2015). doi: 10.1126/science.aab1785; pmid: 26430121
6. M. J. McConnell et al., Mosaic copy number variation in human neurons. Science 342, 632-637 (2013). doi: 10.1126/science.1243472; pmid: 24179226
7. K. A. Knouse, J. Wu, A. Amon, Assessment of megabasescale somatic copy number variation using single-cell sequencing. Genome Res. 26, 376-384 (2016). doi: 10.1101/gr.198937.115; pmid: 26772196
8. X. Cai et al., Single-cell, genome-wide sequencing identifies clonal somatic copy-number variation in the human brain. Cell Reports 8, 1280-1289 (2014). doi: 10.1016/j.celrep.2014.07.043; pmid: 25159146
9. S. K. Rehen et al., Constitutional aneuploidy in the normal human brain. J. Neurosci. 25, 2176-2180 (2005). doi: 10.1523/JNEUROSCI.4560-04.2005; pmid: 15745943
10. Y. B. Yurov et al., Aneuploidy and confined chromosomal mosaicism in the developing human brain. PLOS ONE 2, e558 (2007). doi: 10.1371/journal.pone.0000558; pmid: 17593959
11. K. R. Upton et al., Ubiquitous L1 mosaicism in hippocampal neurons. Cell 161, 228-239 (2015). doi: 10.1016/j.cell.2015.03.026; pmid: 25860606
12. J. K. Baillie et al., Somatic retrotransposition alters the genetic landscape of the human brain. Nature 479, 534-537 (2011). doi: 10.1038/nature10531; pmid: 22037309
13. G. D. Evrony et al., Single-neuron sequencing analysis of L1 retrotransposition and somatic mutation in the human brain. Cell 151, 483-496 (2012). doi: 10.1016/j.cell.2012.09.035; pmid: 23101622
14. G. D. Evrony, E. Lee, P. J. Park, C. A. Walsh, Resolving rates of mutation in the brain using single-neuron genomics. eLife 5, e12966 (2016). doi: 10.7554/eLife.12966; pmid: 26901440
15. J. A. Erwin et al., L1-associated genomic regions are deleted in somatic cells of the healthy human brain. Nat. Neurosci. 19, 1583-1591 (2016).
16. G. D. Evrony et al., Cell lineage analysis in human brain using endogenous retroelements. Neuron 85, 49-59 (2015). doi: 10.1016/j.neuron.2014.12.028; pmid: 25569347
17. J. H. Lui, D. V. Hansen, A. R. Kriegstein, Development and evolution of the human neocortex. Cell 146, 18-36 (2011). doi: 10.1016/j.cell.2011.06.030; pmid: 21729779
18. A. Macia et al., Engineered LINE-1 retrotransposition in nondividing human neurons. Genome Res. 27, 335-348 (2017).
19. A. R. Muotri, F. H. Gage, Generation of neuronal variability and complexity. Nature 441, 1087-1093 (2006). doi: 10.1038/nature04959; pmid: 16810244
20. D. M. Bushman, J. Chun, The genomically mosaic brain: Aneuploidy and more in neural diversity and disease. Semin. Cell Dev. Biol. 24, 357-369 (2013). doi: 10.1016/j. semcdb.2013.02.003; pmid: 23466288
21. I. Iossifov et al., The contribution of de novo coding mutations to autism spectrum disorder. Nature 515, 216-221 (2014). doi: 10.1038/nature13908; pmid: 25363768
22. D. Freed, J. Pevsner, The contribution of mosaic variants to autism spectrum disorder. PLOS Genet. 12, e1006245 (2016). doi: 10.1371/journal.pgen.1006245; pmid: 27632392
23. M. Fromer et al., De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179-184 (2014). doi: 10.1038/nature12929; pmid: 24463507
24. D. Malhotra, J. Sebat, CNVs: Harbingers of a rare variant revolution in psychiatric genetics. Cell 148, 1223-1241 (2012). doi: 10.1016/j.cell.2012.02.039; pmid: 22424231
25. A. Poduri, G. D. Evrony, X. Cai, C. A. Walsh, Somatic mutation, genomic variation, and neurological disease. Science 341, 1237758 (2013). doi: 10.1126/science.1237758; pmid: 23828942
26. J. H. Lee, Somatic mutations in disorders with disrupted brain connectivity. Exp. Mol. Med. 48, e239 (2016).
27. J. M. Sekiguchi et al., Nonhomologous end-joining proteins are required for V(D)J recombination, normal growth, and neurogenesis. Cold Spring Harb. Symp. Quant. Biol. 64, 169-181 (1999). doi: 10.1101/sqb.1999.64.169; pmid: 11232282
28. K. M. Frank et al., DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol. Cell 5, 993-1002 (2000). doi: 10.1016/S1097-2765(00)80264-6; pmid: 10911993
29. M. J. McConnell et al., Failed clearance of aneuploid embryonic neural progenitor cells leads to excess aneuploidy in the Atm-deficient but not the Trp53-deficient adult cerebral cortex. J. Neurosci. 24, 8090-8096 (2004). doi: 10.1523/JNEUROSCI.2263-04.2004; pmid: 15371510
30. N. G. Coufal et al., Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells. Proc. Natl. Acad. Sci. U.S.A. 108, 20382-20387 (2011). doi: 10.1073/pnas.1100273108; pmid: 22159035
31. I. Y. Iourov, S. G. Vorsanova, T. Liehr, A. D. Kolotii, Y. B. Yurov, Increased chromosome instability dramatically disrupts neural genome integrity and mediates cerebellar degeneration in the ataxia-telangiectasia brain. Hum. Mol. Genet. 18, 2656-2669 (2009). doi: 10.1093/hmg/ddp207; pmid: 19414482
32. J. Shen et al., Mutations in PNKP cause microcephaly, seizures and defects in DNA repair. Nat. Genet. 42, 245-249 (2010). doi: 10.1038/ng.526; pmid: 20118933
33. C. M. Carvalho, J. R. Lupski, Mechanisms underlying structural variant formation in genomic disorders. Nat. Rev. Genet. 17, 224-238 (2016). doi: 10.1038/nrg.2015.25; pmid: 26924765
34. Y. L. Chiu, W. C. Greene, The APOBEC3 cytidine deaminases: An innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 26, 317-353 (2008). doi: 10.1146/annurev. immunol.26.021607.090350; pmid: 18304004
35. M. F. Arlt, T. E. Wilson, T. W. Glover, Replication stress and mechanisms of CNV formation. Curr. Opin. Genet. Dev. 22, 204-210 (2012). doi: 10.1016/j.gde.2012.01.009; pmid: 22365495
36. P. J. Hastings, J. R. Lupski, S. M. Rosenberg, G. Ira, Mechanisms of change in gene copy number. Nat. Rev. Genet. 10, 551-564 (2009). doi: 10.1038/nrg2593; pmid: 19597530
37. P. C. Wei et al., Long neural genes harbor recurrent DNA break clusters in neural stem/progenitor cells. Cell 164, 644-655 (2016). doi: 10.1016/j.cell.2015.12.039; pmid: 26871630
38. T. E. Wilson et al., Large transcription units unify copy number variants and common fragile sites arising under replication stress. Genome Res. 25, 189-200 (2015). doi: 10.1101/gr.177121.114; pmid: 25373142
39. I. F. King et al., Topoisomerases facilitate transcription of long genes linked to autism. Nature 501, 58-62 (2013). doi: 10.1038/nature12504; pmid: 23995680
40. M. J. Zylka, J. M. Simon, B. D. Philpot, Gene length matters in neurons. Neuron 86, 353-355 (2015). doi: 10.1016/j.neuron.2015.03.059; pmid: 25905808
41. H. W. Gabel et al., Disruption of DNA-methylation-dependent long gene repression in Rett syndrome. Nature 522, 89-93 (2015). doi: 10.1038/nature14319; pmid: 25762136
42. S. R. Richardson et al., The influence of LINE-1 and SINE retrotransposons on mammalian genomes. Microbiol. Spectr. 3, MDNA3-0061-2014 (2015). doi: 10.1128/microbiolspec. MDNA3-0061-2014
43. D. D. Luan, M. H. Korman, J. L. Jakubczak, T. H. Eickbush, Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: A mechanism for non-LTR retrotransposition. Cell 72, 595-605 (1993). doi: 10.1016/0092-8674(93)90078-5; pmid: 7679954
44. T. A. Morrish et al., DNA repair mediated by endonuclease-independent LINE-1 retrotransposition. Nat. Genet. 31, 159-165 (2002). doi: 10.1038/ng898; pmid: 12006980
45. N. Gilbert, S. Lutz, T. A. Morrish, J. V. Moran, Multiple fates of L1 retrotransposition intermediates in cultured human cells. Mol. Cell. Biol. 25, 7780-7795 (2005). doi: 10.1128/MCB.25.17.7780-7795.2005; pmid: 16107723
46. D. E. Symer et al., Human l1 retrotransposition is associated with genetic instability in vivo. Cell 110, 327-338 (2002). doi: 10.1016/S0092-8674(02)00839-5; pmid: 12176320
47. N. Gilbert, S. Lutz-Prigge, J. V. Moran, Genomic deletions created upon LINE-1 retrotransposition. Cell 110, 315-325 (2002). doi: 10.1016/S0092-8674(02)00828-0; pmid: 12176319
48. J. M. Chen, P. D. Stenson, D. N. Cooper, C. Férec, A systematic analysis of LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease. Hum. Genet. 117, 411-427 (2005). doi: 10.1007/s00439-005-1321-0; pmid: 15983781
49. G. M. Mirzaa et al., Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism. JAMA Neurol. 73, 836-845 (2016). doi: 10.1001/jamaneurol.2016.0363; pmid: 27159400
50. G. M. Mirzaa et al., Characterisation of mutations of the phosphoinositide-3-kinase regulatory subunit, PIK3R2, in perisylvian polymicrogyria: A next-generation sequencing study. Lancet Neurol. 14, 1182-1195 (2015). doi: 10.1016/S1474-4422(15)00278-1; pmid: 26520804
51. J. B. Rivière et al., De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat. Genet. 44, 934-940 (2012). doi: 10.1038/ng.2331; pmid: 22729224
52. E. P. Henske, S. Jóźwiak, J. C. Kingswood, J. R. Sampson, E. A. Thiele, Tuberous sclerosis complex. Nat. Rev. Dis. Primers 2, 16035 (2016). doi: 10.1038/nrdp.2016.35; pmid: 27226234
53. M. D. Shirley et al., Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N. Engl. J. Med. 368, 1971-1979 (2013). doi: 10.1056/NEJMoa1213507; pmid: 23656586
54. C. D. Van Raamsdonk et al., Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457, 599-602 (2009). doi: 10.1038/nature07586; pmid: 19078957
55. S. S. Jamuar et al., Somatic mutations in cerebral cortical malformations. N. Engl. J. Med. 371, 733-743 (2014). doi: 10.1056/NEJMoa1314432; pmid: 25140959
56. F. Sicca et al., Mosaic mutations of the LIS1 gene cause subcortical band heterotopia. Neurology 61, 1042-1046 (2003). doi: 10.1212/WNL.61.8.1042; pmid: 14581661
57. J. G. Gleeson, Classical lissencephaly and double cortex (subcortical band heterotopia): LIS1 and doublecortin. Curr. Opin. Neurol. 13, 121-125 (2000). doi: 10.1097/00019052-200004000-00002; pmid: 10987567
58. T. R. Insel, Brain somatic mutations: The dark matter of psychiatric genetics? Mol. Psychiatry 19, 156-158 (2014). doi: 10.1038/mp.2013.168; pmid: 24342990
59. A. M. D'Gama et al., Targeted DNA sequencing from autism spectrum disorder brains implicates multiple genetic mechanisms. Neuron 88, 910-917 (2015). doi: 10.1016/j.neuron.2015.11.009; pmid: 26637798
60. I. Iossifov et al., De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285-299 (2012). doi: 10.1016/j.neuron.2012.04.009; pmid: 22542183
61. B. M. Neale et al., Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242-245 (2012). doi: 10.1038/nature11011; pmid: 22495311
62. J. Sebat et al., Strong association of de novo copy number mutations with autism. Science 316, 445-449 (2007). doi: 10.1126/science.1138659; pmid: 17363630
63. J. J. Hutsler, M. F. Casanova, Review: Cortical construction in autism spectrum disorder: Columns, connectivity and the subplate. Neuropathol. Appl. Neurobiol. 42, 115-134 (2016). doi: 10.1111/nan.12227; pmid: 25630827
64. A. P. Donovan, M. A. Basson, The neuroanatomy of autism - A developmental perspective. J. Anat. 230, 4-15 (2017). doi: 10.1111/joa.12542; pmid: 27620360
65. M. C. Marchetto et al., Altered proliferation and networks in neural cells derived from idiopathic autistic individuals. Mol. Psychiatry, 10.1038/mp.2016.95 (2016).
66. J. Mariani et al., FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders. Cell 162, 375-390 (2015). doi: 10.1016/j.cell.2015.06.034; pmid: 26186191
67. R. Stoner et al., Patches of disorganization in the neocortex of children with autism. N. Engl. J. Med. 370, 1209-1219 (2014). doi: 10.1056/NEJMoa1307491; pmid: 24670167
68. P. H. Patterson, Maternal infection and immune involvement in autism. Trends Mol. Med. 17, 389-394 (2011). doi: 10.1016/j.molmed.2011.03.001; pmid: 21482187
69. G. B. Choi et al., The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 351, 933-939 (2016). doi: 10.1126/science. aad0314; pmid: 26822608
70. S. E. Smith, R. M. Elliott, M. P. Anderson, Maternal immune activation increases neonatal mouse cortex thickness and cell density. J. Neuroimmune Pharmacol. 7, 529-532 (2012). doi: 10.1007/s11481-012-9372-1; pmid: 22570011
71. N. V. Malkova, C. Z. Yu, E. Y. Hsiao, M. J. Moore, P. H. Patterson, Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav. Immun. 26, 607-616 (2012). doi: 10.1016/j.bbi.2012.01.011; pmid: 22310922
72. H. Soumiya, H. Fukumitsu, S. Furukawa, Prenatal immune challenge compromises development of upper-layer but not deeper-layer neurons of the mouse cerebral cortex. J. Neurosci. Res. 89, 1342-1350 (2011). doi: 10.1002/jnr.22636; pmid: 21674566
73. M. Bundo et al., Increased l1 retrotransposition in the neuronal genome in schizophrenia. Neuron 81, 306-313 (2014). doi: 10.1016/j.neuron.2013.10.053; pmid: 24389010
74. A. R. Muotri et al., L1 retrotransposition in neurons is modulated by MeCP2. Nature 468, 443-446 (2010). doi: 10.1038/nature09544; pmid: 21085180
75. B. B. Lake et al., Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain. Science 352, 1586-1590 (2016). doi: 10.1126/science. aaf1204; pmid: 27339989
76. J. R. Vermeesch, T. Voet, K. Devriendt, Prenatal and preimplantation genetic diagnosis. Nat. Rev. Genet. 17, 643-656 (2016). doi: 10.1038/nrg.2016.97; pmid: 27629932
77. L. Yan et al., Live births after simultaneous avoidance of monogenic diseases and chromosome abnormality by nextgeneration sequencing with linkage analyses. Proc. Natl. Acad. Sci. U.S.A. 112, 15964-15969 (2015). doi: 10.1073/pnas.1523297113; pmid: 26712022
78. Y. Hou et al., Comparison of variations detection between whole-genome amplification methods used in single-cell resequencing. Gigascience 4, 37 (2015). doi: 10.1186/s13742-015-0068-3; pmid: 26251698
79. R. S. Lasken, T. B. Stockwell, Mechanism of chimera formation during the multiple displacement amplification reaction. BMC Biotechnol. 7, 19 (2007). doi: 10.1186/1472-6750-7-19; pmid: 17430586
80. A. Abyzov et al., Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 492, 438-442 (2012). doi: 10.1038/nature11629; pmid: 23160490
81. A. Roth et al., Clonal genotype and population structure inference from single-cell tumor sequencing. Nat. Methods 13, 573-576 (2016). doi: 10.1038/nmeth.3867; pmid: 27183439
82. H. Zafar, Y. Wang, L. Nakhleh, N. Navin, K. Chen, Monovar: Single-nucleotide variant detection in single cells. Nat. Methods 13, 505-507 (2016). doi: 10.1038/nmeth.3835; pmid: 27088313
83. T. Garvin et al., Interactive analysis and assessment of singlecell copy-number variations. Nat. Methods 12, 1058-1060 (2015). doi: 10.1038/nmeth.3578; pmid: 26344043
84. J. L. Hazen et al., The complete genome sequences, unique mutational spectra, and developmental potency of adult neurons revealed by cloning. Neuron 89, 1223-1236 (2016). doi: 10.1016/j.neuron.2016.02.004; pmid: 26948891
85. K. Cibulskis et al., Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213-219 (2013). doi: 10.1038/nbt.2514; pmid: 23396013
86. D. C. Koboldt et al., Var Scan: Variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25, 2283-2285 (2009). doi: 10.1093/bioinformatics/btp373; pmid: 19542151
87. X. Zhao, S. B. Emery, B. Myers, J. M. Kidd, R. E. Mills, Resolving complex structural genomic rearrangements using a randomized approach. Genome Biol. 17, 126 (2016). doi: 10.1186/s13059-016-0993-1; pmid: 27287201
88. R. Xi, S. Lee, Y. Xia, T.-M. Kim, P. J. Park, Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants. Nucleic Acids Res. 44, 6274-6286 (2016). doi: 10.1093/nar/gkw491; pmid: 27260798
89. R. M. Layer, C. Chiang, A. R. Quinlan, I. M. Hall, LUMPY: A probabilistic framework for structural variant discovery. Genome Biol. 15, R84 (2014). doi: 10.1186/gb-2014-15-6-r84; pmid: 24970577
90. A. M. Meynert, M. Ansari, D. R. Fitz Patrick, M. S. Taylor, Variant detection sensitivity and biases in whole genome and exome sequencing. BMC Bioinformatics 15, 247 (2014). doi: 10.1186/1471-2105-15-247; pmid: 25038816
91. E. Lee et al., Landscape of somatic retrotransposition in human cancers. Science 337, 967-971 (2012). doi: 10.1126/science.1222077; pmid: 22745252
92. C. Stewart et al., A comprehensive map of mobile element insertion polymorphisms in humans. PLOS Genet. 7, e1002236 (2011). doi: 10.1371/journal.pgen.1002236; pmid: 21876680
93. S. R. Richardson, S. Morell, G. J. Faulkner, L1 retrotransposons and somatic mosaicism in the brain. Annu. Rev. Genet. 48, 1-27 (2014). doi: 10.1146/annurev-genet-120213-092412; pmid: 25036377
94. C. Z. Zhang et al., Calibrating genomic and allelic coverage bias in single-cell sequencing. Nat. Commun. 6, 6822 (2015). doi: 10.1038/ncomms7822; pmid: 25879913
95. B. J. Hindson et al., High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal. Chem. 83, 8604-8610 (2011). doi: 10.1021/ac202028g; pmid: 22035192
96. A. Piotrowski et al., Somatic mosaicism for copy number variation in differentiated human tissues. Hum. Mutat. 29, 1118-1124 (2008). doi: 10.1002/humu.20815; pmid: 18570184
97. M. O'Huallachain, K. J. Karczewski, S. M. Weissman, A. E. Urban, M. P. Snyder, Extensive genetic variation in somatic human tissues. Proc. Natl. Acad. Sci. U.S.A. 109, 18018-18023 (2012). doi: 10.1073/pnas.1213736109; pmid: 23043118
98. A. R. Muotri et al., Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 435, 903-910 (2005). doi: 10.1038/nature03663; pmid: 15959507
99. N. G. Coufal et al., L1 retrotransposition in human neural progenitor cells. Nature 460, 1127-1131 (2009). doi: 10.1038/nature08248; pmid: 19657334
100. K. C. Kurek et al., Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am. J. Hum. Genet. 90, 1108-1115 (2012). doi: 10.1016/j.ajhg.2012.05.006; pmid: 22658544
101. J. H. Lee et al., De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat. Genet. 44, 941-945 (2012). doi: 10.1038/ng.2329; pmid: 22729223
102. M. J. Lindhurst et al., Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA. Nat. Genet. 44, 928-933 (2012). doi: 10.1038/ng.2332; pmid: 22729222
103. J. B. Rivière et al., De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat. Genet. 44, 934-940 (2012). doi: 10.1038/ng.2331; pmid: 22729224
104. Y. Samuels, V. E. Velculescu, Oncogenic mutations of PIK3CA in human cancers. Cell Cycle 3, 1221-1224 (2004). doi: 10.4161/cc.3.10.1164; pmid: 15467468
105. M. J. Lindhurst et al., A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N. Engl. J. Med. 365, 611-619 (2011). doi: 10.1056/NEJMoa1104017; pmid: 21793738
106. K. Hussain et al., An activating mutation of AKT2 and human hypoglycemia. Science 334, 474 (2011). doi: 10.1126/science.1210878; pmid: 21979934
107. A. Poduri et al., Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 74, 41-48 (2012). doi: 10.1016/j.neuron.2012.03.010; pmid: 22500628
108. J. S. Lim et al., Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat. Med. 21, 395-400 (2015). doi: 10.1038/nm.3824; pmid: 25799227
109. L. Bar-Peled et al., A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 340, 1100-1106 (2013). doi: 10.1126/science.1232044; pmid: 23723238
110. S. Baulac et al., Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations. Ann. Neurol. 77, 675-683 (2015). doi: 10.1002/ana.24368; pmid: 25623524
111. European Chromosome 16 Tuberous Sclerosis Consortium, Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75, 1305-1315 (1993). doi: 10.1016/0092-8674(93)90618-Z; pmid: 8269512
112. M. van Slegtenhorst et al., Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277, 805-808 (1997). doi: 10.1126/science.277.5327.805; pmid: 9242607
113. F. Bourdeaut et al., Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma. J. Med. Genet. 47, 859-862 (2010). doi: 10.1136/jmg.2009.075374; pmid: 20805368
114. S. Gantner et al., Absence of BRAF and HRAS mutations in eruptive Spitz naevi. Br. J. Dermatol. 164, 873-877 (2011). doi: 10.1111/j.1365-2133.2011.10210.x; pmid: 21418173
115. C. Hafner et al., Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern. Proc. Natl. Acad. Sci. U.S.A. 104, 13450-13454 (2007). doi: 10.1073/pnas.0705218104; pmid: 17673550
116. C. Hafner et al., Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J. Clin. Invest. 116, 2201-2207 (2006). doi: 10.1172/JCI28163; pmid: 16841094
117. T. Papp et al., Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi. J. Med. Genet. 36, 610-614 (1999). pmid: 10465111
118. P. M. Pollock et al., High frequency of BRAF mutations in nevi. Nat. Genet. 33, 19-20 (2003). doi: 10.1038/ng1054; pmid: 12447372
119. G. A. Rouleau et al., Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363, 515-521 (1993). doi: 10.1038/363515a0; pmid: 8379998
120. R. M. Cawthon et al., A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62, 193-201 (1990). doi: 10.1016/0092-8674(90)90253-B; pmid: 2114220
121. C. Garcia-Linares et al., Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH. Hum. Mutat. 32, 78-90 (2011). doi: 10.1002/humu.21387; pmid: 21031597
122. L. Messiaen et al., Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1). Hum. Mutat. 32, 213-219 (2011). doi: 10.1002/humu.21418; pmid: 21280148
123. S. A. Rasmussen, J. M. Friedman, NF1 gene and neurofibromatosis 1. Am. J. Epidemiol. 151, 33-40 (2000). doi: 10.1093/oxfordjournals.aje.a010118; pmid: 10625171
124. M. R. Wallace et al., Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients. Science 249, 181-186 (1990). doi: 10.1126/science.2134734; pmid: 2134734
125. L. Groesser et al., BRAF and RAS mutations in sporadic and secondary pyogenic granuloma. J. Invest. Dermatol. 136, 481-486 (2016). doi: 10.1038/JID.2015.376; pmid: 26802240
126. L. Groesser et al., KRAS, HRAS and egfr mutations in sporadic sebaceous gland hyperplasia. Acta Derm. Venereol. 96, 737-741 (2016). pmid: 26804118
127. J. E. Niemela et al., Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis. Blood 117, 2883-2886 (2011). doi: 10.1182/blood-2010-07-295501; pmid: 21079152
128. M. Takagi et al., Autoimmune lymphoproliferative syndromelike disease with somatic KRAS mutation. Blood 117, 2887-2890 (2011). doi: 10.1182/blood-2010-08-301515; pmid: 21063026
129. M. D. Shirley et al., Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N. Engl. J. Med. 368, 1971-1979 (2013). doi: 10.1056/NEJMoa1213507; pmid: 23656586
130. A. C. Thomas et al., Mosaic activating mutations in GNA11 and GNAQ are associated with phakomatosis pigmentovascularis and extensive dermal melanocytosis. J. Invest. Dermatol. 136, 770-778 (2016). doi: 10.1016/j.jid.2015.11.027; pmid: 26778290
131. J. A. Couto et al., A somatic MAP3K3 mutation is associated with verrucous venous malformation. Am. J. Hum. Genet. 96, 480-486 (2015). doi: 10.1016/j.ajhg.2015.01.007; pmid: 25728774
132. J. L. Patten et al., Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N. Engl. J. Med. 322, 1412-1419 (1990). doi: 10.1056/NEJM199005173222002; pmid: 2109828
133. W. F. Schwindinger, C. A. Francomano, M. A. Levine, Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc. Natl. Acad. Sci. U.S.A. 89, 5152-5156 (1992). doi: 10.1073/pnas.89.11.5152; pmid: 1594625
134. E. J. Baxter et al., Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365, 1054-1061 (2005). doi: 10.1016/S0140-6736(05)74230-6; pmid: 15781101
135. R. Kralovics et al., A gain-of-function mutation of JAK2 in myeloproliferative disorders. N. Engl. J. Med. 352, 1779-1790 (2005). doi: 10.1056/NEJMoa051113; pmid: 15858187
136. C. Depienne et al., Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome. J. Med. Genet. 47, 404-410 (2010). doi: 10.1136/jmg.2009.074328; pmid: 20522430
137. N. Tanaka et al., High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: Results of an International Multicenter Collaborative Study. Arthritis Rheum. 63, 3625-3632 (2011). doi: 10.1002/art.30512; pmid: 21702021
138. K. H. Grzeschik et al., Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia. Nat. Genet. 39, 833-835 (2007). doi: 10.1038/ng2052; pmid: 17546031
139. J. Takeda et al., Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73, 703-711 (1993). doi: 10.1016/0092-8674(93)90250-T; pmid: 8500164